ArticleFrontiers in endocrinology2021

Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves' Orbitopathy.

Irene Campi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.